| 번호 | 제목 | 작성자 | 날짜 | 조회 |
|---|---|---|---|---|
| 81 | ※2018년 1월부터는 뉴스레터 PDF 목록에서 제공합니다. | 약제팀 | 2018-02-28 | 916 |
| 80 | 17.12.Osimertinib in Untreated EGFR-Mutated Advanced Non？Small-Cell Lung Cancer | 약제팀 | 2018-01-09 | 1216 |
| 79 | 17.11.Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis | 약제팀 | 2017-12-15 | 994 |
| 78 | 17.10.Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes | 약제팀 | 2017-11-06 | 1026 |
| 77 | 17.09.Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease | 약제팀 | 2017-10-13 | 928 |
| 76 | 17.08.Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist | 약제팀 | 2017-09-07 | 859 |
| 75 | 17.07.Idarucizumab for Dabigatran Reversal - Full Cohort Analysis | 약제팀 | 2017-08-04 | 1055 |
| 74 | 17.06.Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes | 약제팀 | 2017-07-19 | 1072 |
| 73 | 17.05.Angiotensin II for the Treatment of Vasodilatory Shock | 약제팀 | 2017-06-15 | 1129 |
| 72 | 17.04.Palbociclib and Letrozole in Advanced Breast Cancer | 약제팀 | 2017-05-24 | 1150 |
